Literature DB >> 28117800

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.

Wei Wen1, Jian-Ping Zhang1, Wanqiu Chen2, Cameron Arakaki2, Xiaolan Li3, David Baylink2, Gary D Botimer4, Jing Xu1, Weiping Yuan1, Tao Cheng5, Xiao-Bing Zhang6.   

Abstract

Induced Pluripotent Stem Cells (iPSCs) hold great promise for disease modeling and regenerative therapies. We previously reported the use of Episomal Vectors (EV) to generate integration-free iPSCs from peripheral blood mononuclear cells (PB MNCs). The episomal vectors used are DNA plasmids incorporated with oriP and EBNA1 elements from the Epstein-Barr (EB) virus, which allow for replication and long-term retainment of plasmids in mammalian cells, respectively. With further optimization, thousands of iPSC colonies can be obtained from 1 mL of peripheral blood. Two critical factors for achieving high reprogramming efficiencies are: 1) the use of a 2A "self-cleavage" peptide to link OCT4 and SOX2, thus achieving equimolar expression of the two factors; 2) the use of two vectors to express MYC and KLF4 individually. Here we describe a step-by-step protocol for generating integration-free iPSCs from adult peripheral blood samples. The generated iPSCs are integration-free as residual episomal plasmids are undetectable after five passages. Although the reprogramming efficiency is comparable to that of Sendai Virus (SV) vectors, EV plasmids are considerably more economical than the commercially available SV vectors. This affordable EV reprogramming system holds potential for clinical applications in regenerative medicine and provides an approach for the direct reprogramming of PB MNCs to integration-free mesenchymal stem cells, neural stem cells, etc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28117800      PMCID: PMC5408725          DOI: 10.3791/55091

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  37 in total

1.  Cell death associated with abnormal mitosis observed by confocal imaging in live cancer cells.

Authors:  Asher Castiel; Leonid Visochek; Leonid Mittelman; Yael Zilberstein; Francoise Dantzer; Shai Izraeli; Malka Cohen-Armon
Journal:  J Vis Exp       Date:  2013-08-21       Impact factor: 1.355

2.  Generation of iPS Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.

Authors:  Ruijun Jeanna Su; Amanda Neises; Xiao-Bing Zhang
Journal:  Methods Mol Biol       Date:  2016

3.  Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.

Authors:  Tomohisa Seki; Shinsuke Yuasa; Keiichi Fukuda
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

4.  High-efficiency cellular reprogramming with microfluidics.

Authors:  Camilla Luni; Stefano Giulitti; Elena Serena; Luca Ferrari; Alessandro Zambon; Onelia Gagliano; Giovanni G Giobbe; Federica Michielin; Sebastian Knöbel; Andreas Bosio; Nicola Elvassore
Journal:  Nat Methods       Date:  2016-04-18       Impact factor: 28.547

5.  [An improved method for generating integration-free human induced pluripotent stem cells].

Authors:  Shu-Ping Liu; Yan-Xin Li; Jing Xu; Hai-Hui Gu; Hong-Yan Zhang; Hao-Yue Liang; Han-Zhi Liu; Xiao-Bing Zhang; Tao Cheng; Wei-Ping Yuan
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2014-06

6.  The p53-PUMA axis suppresses iPSC generation.

Authors:  Yanxin Li; Haizhong Feng; Haihui Gu; Dale W Lewis; Youzhong Yuan; Lei Zhang; Hui Yu; Peng Zhang; Haizi Cheng; Weimin Miao; Weiping Yuan; Shi-Yuan Cheng; Susanne M Gollin; Tao Cheng
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.

Authors:  Keisuke Okita; Tatsuya Yamakawa; Yasuko Matsumura; Yoshiko Sato; Naoki Amano; Akira Watanabe; Naoki Goshima; Shinya Yamanaka
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

8.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

9.  Purification of specific cell population by fluorescence activated cell sorting (FACS).

Authors:  Sreemanti Basu; Hope M Campbell; Bonnie N Dittel; Avijit Ray
Journal:  J Vis Exp       Date:  2010-07-10       Impact factor: 1.355

10.  Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.

Authors:  Wei Wen; Jian-Ping Zhang; Jing Xu; Ruijun Jeanna Su; Amanda Neises; Guang-Zhen Ji; Weiping Yuan; Tao Cheng; Xiao-Bing Zhang
Journal:  Stem Cell Reports       Date:  2016-05-05       Impact factor: 7.765

View more
  8 in total

1.  [Leukocyte count of puerperal sows].

Authors:  D Mäde; G Wujanz
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1996-09       Impact factor: 0.328

Review 2.  Stem cells and tooth regeneration: prospects for personalized dentistry.

Authors:  Mahmood S Mozaffari; Golnaz Emami; Hesam Khodadadi; Babak Baban
Journal:  EPMA J       Date:  2019-01-07       Impact factor: 6.543

3.  Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells.

Authors:  Yeri Alice Rim; Yoojun Nam; Narae Park; Hyerin Jung; Yeonsue Jang; Jennifer Lee; Ji Hyeon Ju
Journal:  Stem Cells Int       Date:  2018-01-21       Impact factor: 5.443

4.  Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.

Authors:  Xiao-Lan Li; Guo-Hua Li; Juan Fu; Ya-Wen Fu; Lu Zhang; Wanqiu Chen; Cameron Arakaki; Jian-Ping Zhang; Wei Wen; Mei Zhao; Weisheng V Chen; Gary D Botimer; David Baylink; Leslie Aranda; Hannah Choi; Rachel Bechar; Prue Talbot; Chang-Kai Sun; Tao Cheng; Xiao-Bing Zhang
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

5.  R-spondin2 promotes hematopoietic differentiation of human pluripotent stem cells by activating TGF beta signaling.

Authors:  Yv Wang; Jie Gao; Hongtao Wang; Mengge Wang; Yuqi Wen; Jiaojiao Guo; Pei Su; Lihong Shi; Wen Zhou; Jiaxi Zhou
Journal:  Stem Cell Res Ther       Date:  2019-05-20       Impact factor: 6.832

6.  Vitronectin-activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells.

Authors:  Jun Shen; Yaoyao Zhu; Shuo Zhang; Shuzhen Lyu; Cuicui Lyu; Zicen Feng; Dixie L Hoyle; Zack Z Wang; Tao Cheng
Journal:  Cell Prolif       Date:  2021-03-03       Impact factor: 6.831

7.  High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells.

Authors:  Wei Wen; Xinxin Cheng; Yawen Fu; Feiying Meng; Jian-Ping Zhang; Lu Zhang; Xiao-Lan Li; Zhixue Yang; Jing Xu; Feng Zhang; Gary D Botimer; Weiping Yuan; Changkai Sun; Tao Cheng; Xiao-Bing Zhang
Journal:  Stem Cell Reports       Date:  2018-05-10       Impact factor: 7.765

8.  Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood.

Authors:  Haihui Gu; Xia Huang; Jing Xu; Lili Song; Shuping Liu; Xiao-Bing Zhang; Weiping Yuan; Yanxin Li
Journal:  Stem Cell Res Ther       Date:  2018-06-15       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.